Insider Transactions in Q3 2021 at Cytek Biosciences, Inc. (CTKB)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 27
2021
|
Ra Capital Management, L.P. Director |
BUY
Conversion of derivative security
|
Indirect |
6,657,028
+50.0%
|
-
|
|
Jul 27
2021
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
2,950,000
+19.76%
|
$50,150,000
$17.0 P/Share
|
|
Jul 22
2021
|
Wenbin Jiang PRESIDENT AND CEO |
BUY
Conversion of derivative security
|
Indirect |
2,666,600
+50.0%
|
-
|
|
Jul 22
2021
|
Feng Deng Director |
BUY
Conversion of derivative security
|
Indirect |
4,760,510
+50.0%
|
-
|
|
Jul 22
2021
|
Allen Poirson SVP BUS. AND CORP. DEV. |
BUY
Open market or private purchase
|
Direct |
1,500
+3.58%
|
$25,500
$17.0 P/Share
|
|
Jul 22
2021
|
Gisele Dion Director |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$85,000
$17.0 P/Share
|
|
Jul 22
2021
|
Jack Ball |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$51,000
$17.0 P/Share
|
|
Jul 22
2021
|
Valerie Barnett CHIEF LEGAL OFFICER |
BUY
Open market or private purchase
|
Direct |
1,900
+50.0%
|
$32,300
$17.0 P/Share
|